359 related articles for article (PubMed ID: 20712409)
1. The origins of oxidant stress in Parkinson's disease and therapeutic strategies.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
Antioxid Redox Signal; 2011 Apr; 14(7):1289-301. PubMed ID: 20712409
[TBL] [Abstract][Full Text] [Related]
2. What causes the death of dopaminergic neurons in Parkinson's disease?
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
[TBL] [Abstract][Full Text] [Related]
3. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez-Padilla J
Cell Calcium; 2010 Feb; 47(2):175-82. PubMed ID: 20053445
[TBL] [Abstract][Full Text] [Related]
4. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
[TBL] [Abstract][Full Text] [Related]
5. Lower Affinity of Isradipine for L-Type Ca
Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
[TBL] [Abstract][Full Text] [Related]
6. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
Chan CS; Gertler TS; Surmeier DJ
Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
[TBL] [Abstract][Full Text] [Related]
7. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
Guzman JN; Sanchez-Padilla J; Wokosin D; Kondapalli J; Ilijic E; Schumacker PT; Surmeier DJ
Nature; 2010 Dec; 468(7324):696-700. PubMed ID: 21068725
[TBL] [Abstract][Full Text] [Related]
8. Calcium homeostasis, selective vulnerability and Parkinson's disease.
Chan CS; Gertler TS; Surmeier DJ
Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
[TBL] [Abstract][Full Text] [Related]
9. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
Surmeier DJ
Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
[TBL] [Abstract][Full Text] [Related]
10. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
Wang QM; Xu YY; Liu S; Ma ZG
Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
[TBL] [Abstract][Full Text] [Related]
11. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
Surmeier DJ; Halliday GM; Simuni T
Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
[TBL] [Abstract][Full Text] [Related]
12. Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.
Guzman JN; Ilijic E; Yang B; Sanchez-Padilla J; Wokosin D; Galtieri D; Kondapalli J; Schumacker PT; Surmeier DJ
J Clin Invest; 2018 Jun; 128(6):2266-2280. PubMed ID: 29708514
[TBL] [Abstract][Full Text] [Related]
13. Calcium and Parkinson's disease.
Surmeier DJ; Schumacker PT; Guzman JD; Ilijic E; Yang B; Zampese E
Biochem Biophys Res Commun; 2017 Feb; 483(4):1013-1019. PubMed ID: 27590583
[TBL] [Abstract][Full Text] [Related]
14. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
15. Physiological phenotype and vulnerability in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez J; Schumacker PT
Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a009290. PubMed ID: 22762023
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.
Trist BG; Hare DJ; Double KL
Aging Cell; 2019 Dec; 18(6):e13031. PubMed ID: 31432604
[TBL] [Abstract][Full Text] [Related]
17. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
19. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
Chan CS; Guzman JN; Ilijic E; Mercer JN; Rick C; Tkatch T; Meredith GE; Surmeier DJ
Nature; 2007 Jun; 447(7148):1081-6. PubMed ID: 17558391
[TBL] [Abstract][Full Text] [Related]
20. The pathology roadmap in Parkinson disease.
Surmeier DJ; Sulzer D
Prion; 2013; 7(1):85-91. PubMed ID: 23324593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
